SOLICITATION NOTICE
A -- NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases
- Notice Date
- 7/20/2022 9:23:39 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- BAA-DAIT-75N93022R00009
- Response Due
- 10/14/2022 12:00:00 PM
- Archive Date
- 10/29/2022
- Point of Contact
- Brandon de White, Phone: 2406695149, Tom Bahrami, Phone: 2406695147
- E-Mail Address
-
whitebra@niaid.nih.gov, bahramit@niaid.nih.gov
(whitebra@niaid.nih.gov, bahramit@niaid.nih.gov)
- Description
- The objective of this BAA is to support the pre-clinical development of novel vaccine adjuvants towards licensure for human use. For the purposes of this solicitation, vaccine adjuvants are defined using the U.S. Food and Drug�Administration (FDA) definition: Vaccine adjuvants are agents added to, or used in conjunction with, vaccine antigens�to augment or potentiate, and possibly target the specific immune response to the antigen. Please see the attached solicitation document for further details.�
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/135d96abcfc6460791d39de6c1ebc3ca/view)
- Record
- SN06395170-F 20220722/220720230112 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |